Enteric fever in returning travellers: Role of outpatient parenteral antibiotic therapy

Journal of Infection

Volumn 64, Issue 2, 2012, Pages 242-245

  White, B ^a   Coia, J E ^b   Sykes, C ^a   Mather, H ^b   Seaton, R A ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; NALIDIXIC ACID;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; LETTER; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; RECURRENT INFECTION; RELAPSE; RETROSPECTIVE STUDY; SEPTIC SHOCK; TRAVEL; TREATMENT DURATION; TYPHOID FEVER;

FEMALE; HUMANS; MALE; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 84855876830     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.11.019     Document Type: Letter

References (12)

1. Clark T.W., Daneshvar C., Pareek M., Perera N., Stephenson I. Enteric fever in a UK regional infectious disease unit: a 10 year retrospective review. J Infect 2010, 60:91-98.
2. Chau T.T., Campbell J.I., Galindo C.M., et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanisms of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 2007, 51(12):4315-4323.
3. Parry C.M., Hien T.T., Dougan G., White N.J., Farrar J.J. Typhoid fever. N Engl J Med 2002, 347(22):1770.
4. Bhutta Z.A., Khan I.A., Shadmani M. Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan. Antimicrob Agents Chemother 2000, 44:450.
5. Seaton R.A., Sharp E., Bezlyak V., Weir C.J. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents 2011, 38:243-248.
6. Mackintosh C.L., White H.A., Seaton R.A. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob Chemother 2011, 66(2):408-415.
7. Seaton R.A., Bell E., Gourlay Y., Semple L. Nurse-led management of uncomplicated cellulitis in the community; evaluation of a protocol incorporating intravenous ceftriaxone. J Antimicrob Chemother 2005, 55:764-767.
8. Frost J.A. Testing of resistance to antimicrobial drugs. Methods in practical laboratory microbiology 1994, 78-82. CRC Press, New York. H. Chart (Ed.).
9. Effa E.E., Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2008, 4. CD006083.
10. Summary of Product Characteristics for azithromycin, found at: http://www.medicines.org.uk/EMC/medicine/21720/SPC/Azithromycin+500mg+Tablets/%23CLINICAL_PRECAUTIONS.
11. Andrews J.M. BSAC Working Party on susceptibility testing. BSAC standardized disc susceptibility testing method (version 7). J Antimicrob Chemother 2008, 62:256-278.
12. Malloy A., Nair S., Cooke F.J., et al. First report of Salmonella enterica serotype Paratyphi A azithromycin resistance leading to treatment failure. J Clin Microbiol 2010, 48(12):4655-4657.